Boudou-Rouquette P - Search Results

1

Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.

Arrondeau J, Huillard O, Tlemsani C, Cessot A, Boudou-Rouquette P, Blanchet B, Thomas-Schoemann A, Vidal M, Tigaud JM, Durand JP, Alexandre J, Goldwasser F. Arrondeau J, et al. Expert Opin Investig Drugs. 2015 May;24(5):673-87. doi: 10.1517/13543784.2015.1005736. Epub 2015 Jan 20. Expert Opin Investig Drugs. 2015. PMID: 25599887 Review.

2

Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study.

Duffaud F, Blay JY, Le Cesne A, Chevreau C, Boudou-Rouquette P, Kalbacher E, Penel N, Perrin C, Laurence V, Bompas E, Saada-Bouzid E, Delcambre C, Bertucci F, Cancel M, Schiffler C, Monard L, Bouvier C, Vidal V, Gaspar N, Chabaud S. Duffaud F, et al. Among authors: boudou rouquette p. Br J Cancer. 2023 Dec;129(12):1940-1948. doi: 10.1038/s41416-023-02413-9. Epub 2023 Nov 1. Br J Cancer. 2023. PMID: 37914801 Clinical Trial.

3

Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.

Couderc AL, Liuu E, Boudou-Rouquette P, Poisson J, Frelaut M, Montégut C, Mebarki S, Geiss R, Ap Thomas Z, Noret A, Pierro M, Baldini C, Paillaud E, Pamoukdjian F. Couderc AL, et al. Nutrients. 2023 Feb 27;15(5):1193. doi: 10.3390/nu15051193. Nutrients. 2023. PMID: 36904192 Free PMC article. Review.

4

A Two-Step Frailty Assessment Strategy in Older Patients With Solid Tumors: A Decision Curve Analysis.

González Serrano A, Laurent M, Barnay T, Martínez-Tapia C, Audureau E, Boudou-Rouquette P, Aparicio T, Rollot-Trad F, Soubeyran P, Bellera C, Caillet P, Paillaud E, Canouï-Poitrine F. González Serrano A, et al. J Clin Oncol. 2023 Feb 1;41(4):826-834. doi: 10.1200/JCO.22.01118. Epub 2022 Oct 28. J Clin Oncol. 2023. PMID: 36306481 Free PMC article.

5

Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.

Brahmi M, Gaspar N, Gantzer J, Toulmonde M, Boudou-Rouquette P, Bompas E, Firmin N, Valentin T, Cancel M, Duffaud F, Bertucci F, Perrin C, Dufresne A, Marec-Bérard P, Jean-Denis M, Ray-Coquard I, Le Loarer F, Pierron G, Tirode F, Blay JY, Watson S. Brahmi M, et al. Cancer Med. 2023 Apr;12(7):7801-7807. doi: 10.1002/cam4.5539. Epub 2022 Dec 20. Cancer Med. 2023. PMID: 36537582 Free PMC article.

6

Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient.

Boudou-Rouquette P, Alexandre J, Soubrane O, Bertagna X, Goldwasser F. Boudou-Rouquette P, et al. Ann Oncol. 2009 Oct;20(10):1747. doi: 10.1093/annonc/mdp378. Epub 2009 Jul 24. Ann Oncol. 2009. PMID: 19633056 Free article. No abstract available.

7

Safety of bevacizumab 7.5 mg/kg infusion over 10 minutes in NSCLC patients.

Mir O, Alexandre J, Coriat R, Ropert S, Boudou-Rouquette P, Bui T, Chapron J, Durand JP, Dusser D, Goldwasser F. Mir O, et al. Invest New Drugs. 2012 Aug;30(4):1756-60. doi: 10.1007/s10637-011-9690-9. Epub 2011 May 26. Invest New Drugs. 2012. PMID: 21614447

8

Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.

Tod M, Mir O, Bancelin N, Coriat R, Thomas-Schoemann A, Taieb F, Boudou-Rouquette P, Ropert S, Michels J, Abbas H, Durand JP, Dauphin A, Vidal M, Goldwasser F, Blanchet B. Tod M, et al. Pharm Res. 2011 Dec;28(12):3199-207. doi: 10.1007/s11095-011-0499-1. Epub 2011 Jun 21. Pharm Res. 2011. PMID: 21691893

9

Sorafenib exposure decreases over time in patients with hepatocellular carcinoma.

Arrondeau J, Mir O, Boudou-Rouquette P, Coriat R, Ropert S, Dumas G, Rodrigues MJ, Rousseau B, Blanchet B, Goldwasser F. Arrondeau J, et al. Invest New Drugs. 2012 Oct;30(5):2046-9. doi: 10.1007/s10637-011-9764-8. Epub 2011 Oct 29. Invest New Drugs. 2012. PMID: 22038662

10

Sorafenib-induced diarrhea and hypophosphatemia: mechanisms and therapeutic implications.

Mir O, Coriat R, Boudou-Rouquette P, Durand JP, Goldwasser F. Mir O, et al. Ann Oncol. 2012 Jan;23(1):280-281. doi: 10.1093/annonc/mdr525. Epub 2011 Nov 4. Ann Oncol. 2012. PMID: 22056851 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page